Pear Therapeutics, Inc. (PEAR): Price and Financial Metrics


Pear Therapeutics, Inc. (PEAR): $4.27

0.68 (+18.94%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

PEAR Stock Price Chart Interactive Chart >

Price chart for PEAR

PEAR Price/Volume Stats

Current price $4.27 52-week high $14.60
Prev. close $3.59 52-week low $2.81
Day low $3.51 Volume 251,500
Day high $4.34 Avg. volume 334,327
50-day MA $4.73 Dividend yield N/A
200-day MA $7.13 Market Cap 588.56M

Pear Therapeutics, Inc. (PEAR) Company Bio


Pear Therapeutics, Inc. engages in developing and commercializing software-based medicines. The company has a pipeline of products and product candidates across therapeutic areas, including severe psychiatric and neurologic conditions. Its products include PearConnect, a patient service center for prescription digital therapeutics; reSET for the treatment of substance use disorder; reSET-O for the treatment of opioid use disorder; and Somryst for the treatment of chronic insomnia. The company was founded in 2013 and is based in Boston, Massachusetts.


PEAR Latest News Stream


Event/Time News Detail
Loading, please wait...

PEAR Latest Social Stream


Loading social stream, please wait...

View Full PEAR Social Stream

Latest PEAR News From Around the Web

Below are the latest news stories about Pear Therapeutics Inc that investors may wish to consider to help them evaluate PEAR as an investment opportunity.

Pear Therapeutics Announces New CMS HCPCS Code for Prescription Digital Behavioral Therapy Inclusive of All of Its Commercial Products

BOSTON, February 24, 2022--Pear Therapeutics Announces New CMS HCPCS Code for Prescription Digital Behavioral Therapy Inclusive of All of Its Commercial Products

Yahoo | February 24, 2022

Pear Therapeutics to Participate in Citi’s 2022 Virtual Healthcare Conference

BOSTON, February 17, 2022--Pear Therapeutics to Participate in Citi’s 2022 Virtual Healthcare Conference

Yahoo | February 17, 2022

Pear Therapeutics Announces Availability of reSET® and reSET-O® in Spanish

BOSTON, February 15, 2022--Pear Therapeutics Announces Availability of reSET® and reSET-O® in Spanish

Yahoo | February 15, 2022

Pear Therapeutics Announces State of Michigan to Fund Access to Prescription Digital Therapeutics for Substance Use and Opioid Use Disorders

BOSTON, February 10, 2022--Pear Therapeutics Announces State of Michigan to Fund Access to Prescription Digital Therapeutics for Substance Use and Opioid Use Disorders

Yahoo | February 10, 2022

2 “Strong Buy” Penny Stocks That Could Rally to $10 (or More)

The stock markets have started off 2022 with increased volatility, and that’s opened up opportunities for investors – especially for investors willing to shoulder some additional risk. The sharp decline in January lowered prices, while the rapid swings we’ve seen in recent trading sessions makes it possible to take advantage of the lowered entry point. A market situation like this should naturally bring investors’ attention to the penny stocks. These low-cost equities, typically priced below $5 per share, are perfectly placed to bring the high-powered returns when markets move back to a bullish trend.

Michael Marcus on TipRanks | February 8, 2022

Read More 'PEAR' Stories Here

PEAR Price Returns

1-mo -1.61%
3-mo 11.20%
6-mo -57.17%
1-year N/A
3-year N/A
5-year N/A
YTD -31.13%
2021 N/A
2020 N/A
2019 N/A
2018 N/A
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.6925 seconds.